KSPCB Restores One-Time Biomedical Waste Authorisation for Non-Bedded Healthcare Facilities in Kerala

The Kerala State Pollution Control Board (KSPCB) has changed the compliance route for non-bedded healthcare facilities in Kerala. Under Circular No. KSPCB/651/2026-SEE-1, dated 14 August, 2026, these facilities will continue with a one-time authorisation under the Bio-Medical Waste Management Rules 2016, rather than being required to move to integrated consent merely because of the earlier KSPCB circulars discussed in the new document.

The change is especially relevant to small and medium clinics, laboratories and other healthcare establishments that do not have inpatient beds but generate biomedical waste. It also addresses facilities that obtained integrated consent after 12 February 2025, applications that are still pending, and differences between the consent fee already paid and the applicable authorisation fee.

The circular simplifies the approval route, but it does not remove biomedical-waste management responsibilities. A non-bedded facility must still identify the approval that applies to its own operations, maintain compliant waste-management arrangements and follow any conditions attached to its authorisation.

For businesses looking for KSPCB biomedical waste authorisation, the key point is that the one-time authorisation route continues for covered non-bedded healthcare facilities. This is particularly relevant when applying for biomedical waste authorisation for clinics, diagnostic centres and similar establishments.

Notification at a Glance

Simply put, KSPCB is no longer asking the affected non-bedded facilities to move to integrated consent. They can continue with the one-time BMW authorisation Kerala route, while facilities that already obtained integrated consent during the specified period can continue under the transitional arrangement.

Why KSPCB Reconsidered the Earlier Approach

The circular says that after the Central Pollution Control Board issued its direction on 12 February 2025, KSPCB asked non-bedded healthcare facilities with biomedical-waste authorisation to also obtain consent.

Medical, paramedical and laboratory associations subsequently raised concerns about moving from the existing authorisation system to integrated consent. According to the circular, the concerns were connected with the separate siting norms and fee slab applicable to green-category units.

The representations also highlighted the practical position of many small and medium non-bedded facilities:

• They generate limited quantities of biomedical waste.
• They already hold KSPCB authorisation under the Bio-Medical Waste Management Rules 2016.
• They are registered with approved Common Bio-Medical Waste Treatment Facilities (CBWTFs) for the collection, treatment and disposal of biomedical waste.

KSPCB states that it examined the matter in detail. It considered Rule 10 of the Bio-Medical Waste Management Rules, 2016 and the pollution index of 25 assigned to non-bedded healthcare facilities in the CPCB direction dated 12 February 2025. On that basis, KSPCB decided to continue the one-time authorisation system.

This background matters because the new circular is not a general exemption from environmental regulation. It is a correction to the approval route that KSPCB considers appropriate for this category of healthcare establishment.

The KSPCB non-bedded healthcare facility circular is therefore important for facilities that had been preparing to shift from biomedical-waste authorisation to integrated consent based on the earlier instructions.

The Regulatory Framework

The approval route becomes clearer when you look at the rules behind KSPCB’s latest decision.

1. Bio-Medical Waste Management Rules, 2016

The Bio-Medical Waste Management Rules, 2016 cover how biomedical waste is generated, handled, treated and disposed of. Rule 10 sets out the authorisation process.

For non-bedded facilities, Rule 10 provides for one-time authorisation. If the facility later changes its waste generation, handling or disposal activities, it must inform the prescribed authority and seek modification where required.

KSPCB has relied on this provision to continue the one-time authorisation route for eligible non-bedded healthcare facilities.

This supports biomedical waste authorisation for laboratories, clinics and other eligible facilities instead of requiring integrated consent solely because of the earlier circulars.

2. Consent under the Water and Air Acts

It is important not to treat pollution consent and BMW authorisation as the same approval. They cover different areas:

• Water Act consent deals with activities that may cause water pollution or involve discharges.
• Air Act consent applies to activities covered by air-pollution control requirements.
• Biomedical-waste authorisation is specifically for managing biomedical waste under the 2016 Rules.

So, getting one approval does not automatically replace the other. However, under the 14 August 2026 KSPCB circular, eligible non-bedded HCFs can continue with one-time BMW authorisation instead of moving to integrated consent solely because of the earlier requirement.

This does not mean every non-bedded HCF is exempt from other environmental approvals. Facilities with additional activities, emissions, effluent, equipment or expansion should check their specific requirements.

3. Role of KSPCB

KSPCB handles the authorisation and pollution-control matters covered by the circular. It will also process fresh applications, pending cases and fee adjustments.

For Kerala Pollution Control Board HCF authorisation, the correct route depends on the facility's actual operations, waste generation and existing approvals.

Who Is Covered by the Circular?

The circular applies to non-bedded healthcare facilities in Kerala. It does not provide an exhaustive list of establishments falling within that expression.

In everyday business terms, a non-bedded healthcare facility generally means a healthcare establishment that does not provide inpatient beds. Depending on its actual activities and KSPCB classification, the category may include clinics, diagnostic centres or laboratories that generate biomedical waste without operating as bedded hospitals or nursing homes.

Businesses should not rely only on their trade name. A “clinic,” “laboratory,” “day-care centre” or similar establishment may carry out different activities at different sites. Applicability should be checked against the facility's actual operations, waste streams, equipment and approvals.

The applicability of non-bedded HCF consent Kerala requirements should therefore be assessed carefully rather than assuming that every clinic or laboratory automatically follows the same route.

What Has Changed?

The practical change is the withdrawal of the earlier requirement, described in the circular, that all non-bedded HCFs holding KSPCB biomedical-waste authorisation must apply for and obtain consent.

The circular does not cancel biomedical-waste regulation. It changes how the covered non-bedded HCFs are authorised and how transitional consent cases will be handled.

This means a business searching for KSPCB integrated consent healthcare facilities guidance should distinguish between facilities that genuinely require integrated consent for their activities and non-bedded HCFs that fall under the one-time BMW authorisation route described in the new circular.

Effect on the Earlier KSPCB Circulars

The new document refers to Circular No. KSPCB/258/2025-SEE-1, and mentions the dates 14 May 2025 and 10 April 2026. In its final paragraph, it states that the new circular is issued in partial modification of the circular dated 14 May 2025 and supersedes the circular dated 10 April 2026.

“Partial modification”, and “supersession” are not the same. Partial modification changes only the relevant part of the earlier document. Supersession means the later circular replaces the earlier circular for the covered subject. Businesses should retain all three documents in their compliance records because the 2026 circular refers back to the earlier instruments.

The KSPCB circular 14 August 2026 is particularly relevant when reviewing the status of applications, existing consents and BMW authorisations issued during the transition period.

Which Approval Route Applies to Your Facility?

The answer depends on the facility's application history.

Implementation Timeline and Important Dates

The circular does not mention any separate effective date. It was issued on 14 August 2026, and sets out how KSPCB offices should handle the covered facilities as well as applications. So, it is better to refer to 14 August 2026 as the issue date, rather than calling it a separate effective date. The circular does not separately state that it comes into force on a later date. It is dated 14 August.

Treatment of Fresh Applications

A new non-bedded healthcare facility must follow the one-time biomedical-waste authorisation route recognised by the circular.

The circular says that the fee pattern followed before the issue of the referenced earlier circular will apply to fresh authorisation applications. It does not reproduce the fee table, amount, form, list of documents, payment method or online workflow.

A fresh applicant should therefore:

1. Confirm with KSPCB that the establishment is classified as a non-bedded healthcare facility.
2. Identify the biomedical-waste streams generated by the facility.
3. Confirm the current application form, portal and supporting-document checklist.
4. Verify the applicable authorisation fee rather than using the consent fee slab.
5. Keep evidence of its arrangement with an approved CBWTF where applicable.
6. Submit complete information about the facility's operations and waste-management system.

The official website of KSPCB’s has information on healthcare fees and the biomedical-waste authorisation checklist. Applicants should check the latest portal instructions before filing, as the circular does not explain how the online process will be updated.

For facilities that need assistance, biomedical waste authorisation services can help with document preparation, application review and understanding the applicable KSPCB filing route.

Status of Integrated Consents Already Issued

The circular gives a specific transitional benefit to non-bedded HCFs that obtained integrated consent under the Water Act, Air Act, and Environment (Protection) Act framework during the period from 12 February 2025 to 14 August 2026.

These facilities:

• Do not need to obtain a separate biomedical-waste authorisation.
• Will have the authorisation issued through the integrated consent treated as perpetual, according to the circular.
• May need fee reconciliation, depending on whether the consent fee paid was lower or higher than the authorisation fee.

The word “perpetual” should not be understood as permission to ignore operational changes. If the facility changes the manner in which biomedical waste is generated, handled, treated or disposed of, the governing rules may require intimation and modification of the authorisation conditions. The facility must also continue following the conditions of its existing approval and the substantive requirements of the Bio-Medical Waste Management Rules, 2016.

Facilities relying on this transitional treatment should keep copies of:

• The integrated consent
• The authorisation forming part of or issued through that consent
• The application and fee receipt
• Proof of the date of grant
• CBWTF agreement or registration records, where applicable
• Any KSPCB correspondence about fee adjustment or status

The circular does not expressly require all these records to be resubmitted. Keeping them is a practical internal control that will make it easier to establish eligibility for the transitional treatment.

Treatment of Pending Consent Applications

KSPCB states that consent applications already under processing will be disposed of in accordance with the 14 August 2026 circular.

This indicates that a pending application should no longer be processed as if the superseded approach remained unchanged. However, the circular does not explain whether KSPCB will:

• Move the existing consent application to the authorisation process
• Ask the applicant to submit a new or revised form
• Close the existing application and ask for a fresh authorisation application
• Adjust the fee already paid
• Ask for additional documents

If your application is still pending, do not withdraw it or submit another application on your own. First, contact the concerned KSPCB office, mention your application number and Circular No. KSPCB/651/2026-SEE-1 and request written confirmation of the next step.

This is especially important for businesses that have already paid a KSPCB consent fee and are unsure whether the amount will be transferred, adjusted or refunded.

Fee Adjustment and Refund Rules

The circular recognises that facilities which moved to integrated consent may have paid an amount different from the applicable biomedical-waste authorisation fee.

When a balance may be payable

If the consent fee already remitted by the facility is less than the authorisation fee that should apply under the restored route, the facility must pay the difference.

The circular does not state:

• How KSPCB will calculate and communicate the shortfall
• Which payment link or account must be used
• Whether the facility must act without a demand notice
• The deadline for payment
• The consequence of delayed payment

The HCF should therefore obtain an official fee calculation or demand from KSPCB before remitting an amount.

When a refund may be due

If the consent fee paid exceeds the authorisation fee, the circular says the excess will be refunded.

It does not specify:

• Whether KSPCB will process the refund automatically
• Whether the HCF needs to submit a separate refund request
• Which documents need to be submitted
• Which KSPCB office will handle the refund
• How bank details should be provided
• How long the refund will take
• Whether any deduction will be made

This uncertainty can make it difficult for facilities to know what to do next. For now, keep the fee receipt, consent application, approval, payment proof and bank details ready. If you apply for a refund, mention Circular No. KSPCB/651/2026-SEE-1 and keep an acknowledgement of your request. These are practical steps, as the circular itself does not lay down a formal refund procedure.

Businesses requiring assistance with this process can consider KSPCB compliance consulting for document review, fee reconciliation and application follow-up.

What Compliance Duties Continue?

The circular simplifies the approval route, it does not relax the underlying responsibility to manage biomedical waste safely.

A covered facility should continue to:

• Follow the Bio-Medical Waste Management Rules, 2016 and the conditions of its authorisation.
• Maintain its arrangement with an approved CBWTF where that arrangement applies.
• Ensure that biomedical waste is collected, treated and disposed of through an authorised system.
• Keep approval, fee and waste-management records available for verification.
• Review whether a change in services, equipment, waste generation or waste handling needs to be reported to KSPCB.
• Check whether any separate environmental approval applies because of an activity not addressed by this circular.

The circular itself does not provide a new technical checklist for segregation, storage, labelling, transport, training or reporting. Those duties arise from the governing rules and the conditions of the facility's authorisation, not from this two-page administrative circular alone.

Impact on Healthcare Businesses

The latest circular gives healthcare businesses a clearer approval route, while reducing confusion around consent, authorisation, fees and pending applications.

• Small Clinics and Diagnostic Facilities

For small non-bedded clinics and diagnostic centres, the biggest change is simpler compliance. Eligible facilities can continue with one-time biomedical-waste authorisation instead of shifting to integrated consent. This can reduce duplicate paperwork, especially for facilities that already generate limited biomedical waste and work with an approved CBWTF. The update is particularly relevant for businesses seeking biomedical waste authorisation for clinics and small diagnostic establishments.

• Facilities That Already Obtained Integrated Consent

Some non-bedded HCFs had already taken integrated consent before this change. If yours was issued between 12 February 2025 and 14 August 2026, you do not have to get a separate BMW authorisation. Check your consent and payment records once. If you paid less than the applicable authorisation fee, you will have to pay the difference. If you paid more, KSPCB will refund the excess. It is also worth checking that your authorisation is correctly reflected in the records as perpetual.

• Applicants With Pending Files

Facilities with pending consent applications may need to wait for KSPCB to apply the revised process. The circular does not explain whether pending files will be converted, closed or adjusted, so applicants should actively follow up with the concerned KSPCB office and avoid filing a duplicate application without confirmation.

• KSPCB Offices and Compliance Teams

KSPCB offices now have to apply the new approach to fresh, existing and pending cases. At the same time, healthcare associations and compliance teams need to update their earlier guidance, especially where they had advised non-bedded HCFs to move from BMW authorisation to integrated consent.

Benefits and Implementation Challenges

The circular brings welcome clarity for non-bedded healthcare facilities, but a few practical questions still need clear direction from KSPCB.

Likely benefits

• Restores the one-time-authorisation approach recognised under Rule 10 for non-bedded occupiers.
• Reduces the risk of duplicate approvals for facilities that have already obtained integrated consent.
• Protects the status of integrated consents issued during the stated transition period.
• Creates a basis for refunding excess consent fees.
• Addresses concerns raised by medical, paramedical and laboratory associations.
• Better aligns the approval route with the limited biomedical-waste generation described for many small and medium non-bedded facilities.

Practical challenges

• The refund process and timeline are not stated.
• The balance-fee payment process and deadline are not stated.
• The circular does not explain how pending consent applications will be converted or closed.
• Fresh applicants may need updated portal guidance and application instructions.
• Facilities may struggle to determine whether they are truly non-bedded where services include observation, day care or another mixed model.
• Integrated-consent holders must ensure that KSPCB records the authorisation status and validity correctly.

Overall, the decision appears to reduce unnecessary administrative duplication for the specific category addressed. Its practical success will depend on clear implementation instructions from KSPCB, particularly for online applications, fee reconciliation and pending files.

Matters Not Expressly Clarified

The following points should be confirmed directly with KSPCB where relevant:

1. Separate effective date: The circular is dated 14 August 2026 but does not provide a separately worded effective date.
2. Definition of non-bedded HCF for borderline models: The circular does not list facility types or address establishments offering day-care, observation or mixed services.
3. Fresh-application procedure: It restores the earlier fee pattern but does not reproduce the application form, documents, portal steps or fee amount.
4. Pending-application procedure: It does not say whether applications will be converted, closed, returned or amended.
5. Balance-fee deadline: No payment period or consequence of delay is stated.
6. Refund process: No application form, office, documentation list or processing timeline is stated.
7. Meaning of perpetual validity in changed circumstances: The circular describes the transitional authorisation validity as perpetual, but it does not remove the need to address changes in biomedical-waste activities under the governing rules.
8. Treatment outside the specified integrated-consent window: The circular expressly addresses consents obtained from 12 February 2025 to its issue date, it does not separately explain every scenario outside that period.

These are implementation gaps, not reasons to disregard the circular. A business should obtain written clarification where an unanswered point affects its payment, application or approval status.

Practical Examples

The following examples are illustrations designed to explain the circular. They are not KSPCB rulings on individual facilities.

Example 1: A new diagnostic laboratory without inpatient beds

A diagnostic laboratory opening after the circular should first confirm that KSPCB classifies it as a non-bedded HCF. If it falls within that category, the one-time biomedical-waste authorisation route applies. The laboratory should verify the current application checklist, fee and CBWTF documentation before filing.

This is also the typical situation in which biomedical waste authorisation for laboratories may be required.

Example 2: A clinic that obtained integrated consent in October 2025

Because the consent was obtained between 12 February 2025 and 14 August 2026, the clinic does not need a separate BMW authorisation under the circular. It should retain the integrated consent and check whether its payment is lower or higher than the applicable authorisation fee.

Example 3: A Laboratory with a Pending Consent Application

A laboratory may have submitted its consent application but still be waiting for approval on 14 August 2026. In this case, it should first speak to KSPCB about the existing application. There is no need to file another application until the Board confirms what should be done with the pending file and fee.

Example 4: An Existing Clinic Expanding Its Services

A clinic may already have BMW authorisation, and later decide to add new services. If this means more biomedical waste or a change in how the waste is handled, the clinic should check whether KSPCB needs to be informed or the existing authorisation needs to be changed.

What Non-Bedded Healthcare Facilities Should Do Next

The new circular simplifies the approval process for non-bedded HCFs, but some practical issues around fees, applications and implementation still need clarity.

1. Check whether your facility falls under the non-bedded category. Look at the services you actually provide, rather than relying only on the name of the clinic or laboratory.
2. See what approval you already have. You may have one-time BMW authorisation, integrated consent, or an application that is still pending.
3. Check when the approval was issued. If you have integrated consent, see whether it was granted between 12 February 2025 and 14 August 2026.
4. Keep all your papers together. This includes the consent or authorisation, application, fee receipt and any letters or emails exchanged with KSPCB.
5. Reconcile the fee. Compare the consent fee paid with the applicable authorisation fee, but obtain KSPCB confirmation before paying a shortfall or claiming a refund.
6. Follow up on pending applications. Quote the circular number and seek written guidance from the regional or district KSPCB office.
7. Maintain biomedical-waste compliance. Keep the CBWTF arrangement and other obligations under the rules and approval conditions up to date.
8. Review changes before expansion. New services, equipment, waste streams or handling methods may require intimation or modification even where the authorisation is one-time.

How Corpseed Can Help

The new KSPCB circular simplifies the broad approval route, but individual facilities may still need help determining their correct category, updating a pending file or reconciling fees. Corpseed can support non-bedded healthcare facilities with:

• Applicability assessment for clinics, laboratories and diagnostic centres
• Review of existing BMW authorisation and integrated-consent records
• Assistance with fresh biomedical-waste authorisation applications
• Support in understanding KSPCB documentation and filing requirements
• Review and follow-up of pending consent applications
• Fee-reconciliation and refund-document preparation support
• CBWTF agreement and compliance-document review
• Environmental compliance gap assessment
• Support for approval modification when operations or waste generation change
• Ongoing regulatory monitoring and compliance assistance

Corpseed can also assist businesses seeking KSPCB biomedical waste authorisation services by reviewing the facility profile, identifying the applicable approval route and helping prepare the required documentation.

Corpseed's role is to help businesses prepare accurate documentation, understand the applicable process and communicate effectively with the authority. Approval, fee determination and refund decisions remain with KSPCB.

If your clinic or laboratory is unsure whether it needs fresh authorisation, can rely on an integrated consent, or is eligible for a refund, a document-specific review can help prevent duplicate filings and avoid unsupported assumptions.

Key Takeaways

• KSPCB has confirmed that non-bedded HCFs will continue with one-time authorisation under the Bio-Medical Waste Management Rules, 2016.
• The decision is contained in Circular No. KSPCB/651/2026-SEE-1 dated 14 August 2026.
• Covered facilities that obtained integrated consent between 12 February 2025 and 14 August 2026 need not obtain separate authorisation.
• The circular describes the authorisation issued through those integrated consents as perpetual.
• A fee shortfall must be paid, while consent fees collected above the authorisation fee are to be refunded.
• Pending consent applications will be dealt with under the new circular.
• The circular does not specify the refund process, refund timeline, payment deadline or detailed treatment of pending applications.
• One-time authorisation does not remove the continuing duty to manage biomedical waste in accordance with the governing rules and approval conditions.
• Non-bedded clinics, laboratories and diagnostic facilities should review their current approval status rather than automatically applying for integrated consent.
• Facilities with pending applications or fee differences should obtain clarification from KSPCB before making a duplicate filing or payment.

FAQs

1. Do non-bedded healthcare facilities need KSPCB consent?

No. Covered non-bedded healthcare facilities can continue with one-time biomedical waste authorisation instead of integrated KSPCB consent.

2. Is BMW authorisation one-time for clinics in Kerala?

Yes. Eligible non-bedded clinics in Kerala can continue with one-time BMW authorisation under the Bio-Medical Waste Management Rules, 2016.

3. Do Kerala laboratories need integrated pollution consent?

Not necessarily. Eligible non-bedded laboratories can continue with one-time biomedical waste authorisation under the latest KSPCB circular.

4. What happens to integrated consent already obtained by a non-bedded HCF?

If the consent was issued between 12 February 2025 and 14 August 2026, the facility does not need a separate BMW authorisation.

5. How will KSPCB refund excess consent fees?

KSPCB has said that the extra amount will be refunded. However, the circular does not explain how to apply for the refund or when it will be paid.

6. What happens to pending consent applications of non-bedded HCFs?

KSPCB will deal with pending applications under the new circular. Applicants should check with the concerned office before taking any further step.